M. Pannek

632 total citations
9 papers, 492 citations indexed

About

M. Pannek is a scholar working on Geriatrics and Gerontology, Epidemiology and Oncology. According to data from OpenAlex, M. Pannek has authored 9 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Geriatrics and Gerontology, 8 papers in Epidemiology and 3 papers in Oncology. Recurrent topics in M. Pannek's work include Autophagy in Disease and Therapy (8 papers), Sirtuins and Resveratrol in Medicine (8 papers) and PARP inhibition in cancer therapy (3 papers). M. Pannek is often cited by papers focused on Autophagy in Disease and Therapy (8 papers), Sirtuins and Resveratrol in Medicine (8 papers) and PARP inhibition in cancer therapy (3 papers). M. Pannek collaborates with scholars based in Germany, United States and Italy. M. Pannek's co-authors include Clemens Steegborn, Mike Schutkowski, Wolfgang Sippl, Claudia Roessler, Marat Meleshin, Dante Rotili, Antonello Mai, Tobias Rumpf, David Sinclair and Oliver Einsle and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

M. Pannek

9 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Pannek Germany	9	369	218	166	162	100	9	492
Claudia Roessler Germany	9	327 0.9×	187 0.9×	184 1.1×	152 0.9×	74 0.7×	10	480
Marat Meleshin Germany	11	288 0.8×	169 0.8×	360 2.2×	111 0.7×	162 1.6×	19	614
Jialin Shang China	7	96 0.3×	51 0.2×	225 1.4×	48 0.3×	55 0.6×	12	397
Angela H. Guo United States	8	96 0.3×	74 0.3×	319 1.9×	29 0.2×	34 0.3×	9	439
Julia S. Samaddar United States	4	48 0.1×	208 1.0×	209 1.3×	59 0.4×	55 0.6×	4	346
Qingyan Au United States	9	53 0.1×	41 0.2×	143 0.9×	14 0.1×	43 0.4×	23	230
Wenke Jin China	9	27 0.1×	49 0.2×	169 1.0×	11 0.1×	33 0.3×	17	256
David M. Rees United Kingdom	5	89 0.2×	56 0.3×	347 2.1×	8 0.0×	17 0.2×	7	445
Cynthia Bernier Canada	6	40 0.1×	29 0.1×	105 0.6×	27 0.2×	72 0.7×	8	200
Snahel Patel United States	9	17 0.0×	26 0.1×	187 1.1×	23 0.1×	46 0.5×	10	325

Countries citing papers authored by M. Pannek

Since Specialization

Citations

This map shows the geographic impact of M. Pannek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Pannek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Pannek more than expected).

Fields of papers citing papers by M. Pannek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Pannek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Pannek. The network helps show where M. Pannek may publish in the future.

Co-authorship network of co-authors of M. Pannek

This figure shows the co-authorship network connecting the top 25 collaborators of M. Pannek. A scholar is included among the top collaborators of M. Pannek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Pannek. M. Pannek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Pannek, M., Francesco Fiorentino, Dina Robaa, et al.. (2024). Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity. Journal of Medicinal Chemistry. 67(3). 1843–1860. 8 indexed citations

2.

Tomassi, Stefano, Daniela Passeri, Roberto Pellicciari, et al.. (2020). From PARP1 to TNKS2 Inhibition: A Structure-Based Approach. ACS Medicinal Chemistry Letters. 11(5). 862–868. 11 indexed citations

3.

Meleshin, Marat, M. Pannek, Frank Bordusa, et al.. (2018). Potent and Selective Inhibitors of Human Sirtuin 5. Journal of Medicinal Chemistry. 61(6). 2460–2471. 30 indexed citations

4.

Pannek, M., Matthew Fuszard, Marat Meleshin, et al.. (2017). Crystal structures of the mitochondrial deacylase Sirtuin 4 reveal isoform-specific acyl recognition and regulation features. Nature Communications. 8(1). 1513–1513. 82 indexed citations

5.

Pannek, M., Dhaval P. Bhatt, Matthew D. Hirschey, et al.. (2017). Mechanism‐Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure–Activity Relationship, Biostructural, and Kinetic Insight. Angewandte Chemie. 129(47). 15032–15037. 9 indexed citations

6.

Pannek, M., Dhaval P. Bhatt, Matthew D. Hirschey, et al.. (2017). Mechanism‐Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure–Activity Relationship, Biostructural, and Kinetic Insight. Angewandte Chemie International Edition. 56(47). 14836–14841. 55 indexed citations

7.

Rumpf, Tobias, Matthias Schiedel, Berin Karaman, et al.. (2015). Selective Sirt2 inhibition by ligand-induced rearrangement of the active site. Nature Communications. 6(1). 6263–6263. 227 indexed citations

8.

Roessler, Claudia, M. Pannek, M. Gertz, et al.. (2014). Chemical Probing of the Human Sirtuin 5 Active Site Reveals Its Substrate Acyl Specificity and Peptide‐Based Inhibitors. Angewandte Chemie International Edition. 53(40). 10728–10732. 61 indexed citations

9.

Roessler, Claudia, M. Pannek, M. Gertz, et al.. (2014). Chemical Probing of the Human Sirtuin 5 Active Site Reveals Its Substrate Acyl Specificity and Peptide‐Based Inhibitors. Angewandte Chemie. 126(40). 10904–10908. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact